News

TV Interview with PoC-ID Clinical Research Partner Hospital Clínico de Santiago (in Galician), Mar’16

Televisión de Galicia held an interview recently with PoC-ID Clinical Research Partner Hospital Clínico de Santiago (CHUS).   Link to TV Interview with PoC-ID Partner CHUS   In Galician Investigadores do CHUS participan nun proxecto europeo de diagnose de enfermidades infecciosas Un equipo de investigadores do Hospital Clínico de Santiago participa nun proxecto europeo para […]
read more

CNM Technologies launched “Kickstarter” project

Innovative Membrane Module for Clean Air and Water CNM Technologies’ new membranes can clean polluted water or air more efficiently than other materials. PoC-ID project partner CNM Technologies launched a crowd funding project on the “Kickstarter” platform to collect money for the development and assembly of a demonstrator for gas separation. This demonstrator will show […]
read more

Design for Microfluidic Interfacing White Paper available

A White Paper “Design Guideline for Microfluidic Device and Component Interfaces” has been made available by the MFManufacturing Project, the European initiative for the standardization and manufacturability of complex micro-fluidic (MF) devices. Comments, suggestions and questions regarding this document can be addressed to: Henne van Heeren enablingMNT, The Netherlands E-mail: henne ( at) enablingMNT.com  
read more

EC Call: Valorisation of Health Research Results

EC Call SC1-HCO-01-2016 published: Valorisation of FP7 Health and H2020 SC1 Research Results The objective of this coordination and support action is to develop a European web marketplace referencing all types of innovations such as patents, licensing opportunities, prototypes, products, technologies or services with a potential for future exploitation and/or commercialisation, primarily generated by FP7 […]
read more

PoC-ID Press Release, 7 Oct’15

Breakthrough ultra-sensitive technology to address the main cause of respiratory infection in children Developing a Platform for ultra-sensitive Point-of-Care diagnostics for Infectious Diseases (PoC-ID Project) European funded consortium (Horizon2020) to tackle one of the world’s leading causes of morbidity and hospitalisation 13 teams from 7 countries focused on development and transfer of advanced miniaturised point-of-care […]
read more

Antimicrobial Resistance in G7 Countries and Beyond

from G7 Health Ministers Meeting, Berlin, Germany, 8th October 2015: THE RISE OF ANTIMICROBIAL RESISTANCE Since their discovery, antimicrobial therapies (AMTs) have played an essential role in the treatment of infections in humans and animals and have significantly improved population health. Many of the improvements in mortality and morbidity that modern medicine has secured are […]
read more

CNM Technologies, PoC-ID partner, has succeeded in manufacturing its first carbon nanomembrane in A4 format

Bielefeld, September 2015 – CNM Technologies, based in Bielefeld/Germany, has succeeded in manufacturing its first carbon nanomembrane in A4 format. This success is a major step on the path to an industrial and large scale manufacturing of these highly innovative and disruptive membranes. CNM Technologies manufactures ultrathin membranes on carbon basis, which are only one […]
read more

PoC-ID announced on Cordis

The PoC-ID project has been announced on the European Commission Cordis Website. Screenshot:
read more

The Review on antimicrobial resistance (AMR)

Drug-resistant infections could kill an extra 10 million people across the world every year by 2050 if they are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy, and roughly equivalent to the world losing the output of […]
read more

European Commission launches €1m prize for a diagnostic test to combat antibiotic resistance

News Alert European Commission launches €1m prize for a diagnostic test to combat antibiotic resistance Brussels, 26 February 2015 A prize of €1 million will be awarded to the person or team that develops a rapid test to tell whether a patient needs to be treated with antibiotics or not, the European Commission announced today. […]
read more